Bay City Capital Invests $5 Million in Series A Preferred Stock of SynGen, Inc.

Represented Bay City Capital in connection with its investment in SynGen, Inc.

Bay City Capital was established in 1997 for the purpose of managing investment funds in the life sciences industry. Since that date, they have managed eight venture funds representing over $1.6 billion in capital invested in over 90 companies worldwide.